Under active development. Data is being added and corrected on an hourly basis.

← Back to Peptides

MGF

Growth Hormone
Phase 1 Research
25%
Low-Moderate Risk
2/5

Dosing Protocol

Typical Dose 150 mcg
Range 100 - 200 mcg
Maintenance 150 mcg post-workout
Cycle 4w on / 4w off

Pharmacokinetics

Half-Life 6 min
Onset 2 min
Peak 5 min
Duration 30 min
Bioavailability 85%
Primary Route Subcutaneous

Administration

Routes Subcutaneous, Intramuscular
Injection Sites Target Muscle, Bilateral
Needle Gauge 29-31G
Syringe Type Insulin
Timing Post-Workout, immediately after training

Reconstitution

Diluent Bacteriostatic Water
Volume 1 mL
Concentration 200 mcg/mL
Stability 2 days refrigerated
Vial Sizes 2, 5 mg

Special Instructions

VERY unstable - reconstitute immediately before use. Inject bilaterally into trained muscle groups. Use within 48 hours of reconstitution. PEG-MGF version is more stable.